Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2013 Jan 4;57(2):853. doi: 10.1002/hep.25998

Practice Guidelines on NAFLD

Melissa Palmer 1
PMCID: PMC3600529  PMID: 22886577

To The Editor:

I read with interest the practice guidelines on nonalcoholic fatty liver disease (NAFLD),1 in which the authors fail to reference the association between high fructose corn syrup (HFCS) and NAFLD. The intake of HFCS, a combination of glucose and fructose, has increased over time and parallels both the obesity and NAFLD epidemics.2 Numerous studies demonstrate that the mechanism by which HFCS causes NAFLD is due to fructose. In animal models, fructose causes steatosis and fibrosis3,4 by either increasing hepatic lipogenesis, causing activation of pyruvate dehydrogenase,5 activating inflammatory pathways,6 or up-regulating the expression of sterol regulatory element-binding protein (SREBP).7

In humans, excessive fructose intake can lead to increased hepatic lipid deposition, greater insulin resistance, and hypertriglyceridemia.8 NAFLD patients have been found to drink more HFCS soft drinks compared with healthy controls.9 A retrospective analysis of 341 NAFLD adults found that those consuming high fructose diets had more fibrosis than those consuming low fructose diets.10 A prospective controlled trial with histologic endpoints is needed to define the amount of HFCS safe for NAFLD patients and to determine the extent to which fructose contributes to the pathogenesis and progression of NAFLD. However, there are currently sufficient data to recommend that NAFLD patients refrain from excessive consumption of HFCS.

References

  • 1.Chalasani N, Younossi Z, Lavine J, Diehl AM, Brunt E, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, the American Gastroenterological Association. HEPATOLOGY. 2012;55:2005–2023. doi: 10.1002/hep.25762. [DOI] [PubMed] [Google Scholar]
  • 2.Bray G, Nielsen S, Popkin M. Consumption of HFCS in beverages may play a role in the epidemic of obesity. Am J Clin Nutr. 2004;79:537–543. doi: 10.1093/ajcn/79.4.537. [DOI] [PubMed] [Google Scholar]
  • 3.Anstee Q, Goldin R. Mouse models in NAFLD and steatohepatitis research. Int J Exp Pathol. 2006;87:1–16. doi: 10.1111/j.0959-9673.2006.00465.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Davail S, Rideau N, Bernadet MD, Andre JM, Guy G, Hoo-Paris R. Effects of dietary fructose on liver steatosis in overfed mule ducks. Horm Metab Res. 2005;37:32–35. doi: 10.1055/s-2005-861029. [DOI] [PubMed] [Google Scholar]
  • 5.Park OJ, Cesar D, Faix D, Wu K, Shackleton CH, Hellerstein MK. Mechanisms of fructose-induced hypertriglyceridaemia in the rat. Activation of hepatic pyruvate dehydrogenase through inhibition of pyruvate dehydrogenase kinase. Biochem J. 1992;282(Pt 3):753–757. doi: 10.1042/bj2820753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Kelley GL, Allan G, Azhar S. High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregulation. Endocrinology. 2004;145:548–555. doi: 10.1210/en.2003-1167. [DOI] [PubMed] [Google Scholar]
  • 7.Kanuri G, Spruss A, Wagnerberger S, Bischoff SC, Bergheim I. Role of TNF in the onset of fructose-induced NAFLD in mice. J Nutr Biochem. 2011;22:527–534. doi: 10.1016/j.jnutbio.2010.04.007. [DOI] [PubMed] [Google Scholar]
  • 8.Lê KA, Tappy L, D'Alessio DA. Mitochondrial dysfunction and insulin resistance: a matter of lifestyle? Curr Opin Clin Nutr Metab Care. 2007;10:494–497. doi: 10.1097/MCO.0b013e3281e72abf. [DOI] [PubMed] [Google Scholar]
  • 9.Abid A, Taha O, Nseir W. Soft drink consumption is associated with NAFLD independent of metabolic syndrome. J Hepatol. 2009;51:918–924. doi: 10.1016/j.jhep.2009.05.033. [DOI] [PubMed] [Google Scholar]
  • 10.Abdelmalek MF, Suzuki A, Guy C, Unalp-Arida A, Colvin R, Johnson RV, et al. Increased fructose consumption is associated with fibrosis severity in patients with NAFLD. HEPATOLOGY. 2010;51:1961–1971. doi: 10.1002/hep.23535. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Hepatology (Baltimore, Md.) are provided here courtesy of Wiley

RESOURCES